📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial. (2022)

First Author: Rush HL

Attributed to: Developing Existing Healthcare Technologies to Deliver More Affordable and Effective Cancer Care funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.21.00728

PubMed Identifier: 34757812

Publication URI: http://europepmc.org/abstract/MED/34757812

Type: Journal Article/Review

Volume: 40

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 8

ISSN: 0732-183X